Cutler Group’s Bioventus BVS Stock Holding History

Cutler Group’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,800	Closed	-$3K	–	5343
2021 Q4	$3K	Buy	+13,800	New	+$196K	﹤0.01%	4467

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Cutler Group's BVS Position: Q1 2024 in Review

Cutler Group held its Bioventus (BVS) position steady in Q1 2024 at 4,800 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #945.

Cutler Group first reported a position in BVS in Q4 2021 and has held it in 10 quarters since. The position peaked at $82K in Q4 2021. 84 funds tracked by Wall St. Rank hold BVS as of Q1 2024.

Cutler Group held 4,800 shares of Bioventus worth $24K as of Q1 2024.
Cutler Group left its Bioventus share count unchanged in Q1 2024.
Bioventus made up 0.01% of Cutler Group's portfolio in Q1 2024, its #945 holding.
Cutler Group first reported a position in Bioventus in Q4 2021 and has held it in 10 quarters since.
Cutler Group's Bioventus position peaked at $82K in Q4 2021.
84 funds tracked by Wall St. Rank held Bioventus as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.